Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
| Cat. No. | Especies | Descripción del producto | Estructura | Pureza | Característica |
|---|---|---|---|---|---|
| PR1-H52H4 | Human | Human ProS1 Protein, His Tag |  |
|
|
| PR1-H52H3 | Human | Human ProS1 Protein, His Tag |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Afala | Approved | Materia Medica Holding Research And Production Company | Russian Federation | Prostatic Neoplasms; Prostatitis | Materia Medica Holding Research And Production Company | 2014-01-01 | Prostatic Neoplasms; Prostatitis | Details | ||
| Afala | Approved | Materia Medica Holding Research And Production Company | Russian Federation | Prostatic Neoplasms; Prostatitis | Materia Medica Holding Research And Production Company | 2014-01-01 | Prostatic Neoplasms; Prostatitis | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Prostate cancer vaccine (Advaxis) | ADXS-PSA; ADXS-31142 | Phase 2 Clinical | Advaxis Inc | Neoplasms; Prostatic Neoplasms | Details |
| TP-122A | TP-122A | Phase 2 Clinical | Vector B2B, Technophage SA | Pneumonia, Ventilator-Associated | Details |
| GEA-408 | GEA-408 | Phase 2 Clinical | GenEros Biopharma Hangzhou Ltd | Prostatic Neoplasms | Details |
| P-PSMA-101 | P-PSMA-101 | Phase 1 Clinical | Poseida Therapeutics Inc | Genital Neoplasms, Male; Salivary Gland Neoplasms; Neoplasms; Carcinoma, Adenoid Cystic; Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms; Carcinoma, Mucoepidermoid; Carcinoma, Acinar Cell; Urogenital Neoplasms; Prostatic Diseases | Details |
| Prostate cancer subunit vaccine (Progenics) | Phase 1 Clinical | Progenics Pharmaceuticals Inc | Prostatic Neoplasms | Details | |
| Prostate cancer vaccine (Advaxis) | ADXS-PSA; ADXS-31142 | Phase 2 Clinical | Advaxis Inc | Neoplasms; Prostatic Neoplasms | Details |
| TP-122A | TP-122A | Phase 2 Clinical | Vector B2B, Technophage SA | Pneumonia, Ventilator-Associated | Details |
| GEA-408 | GEA-408 | Phase 2 Clinical | GenEros Biopharma Hangzhou Ltd | Prostatic Neoplasms | Details |
| P-PSMA-101 | P-PSMA-101 | Phase 1 Clinical | Poseida Therapeutics Inc | Genital Neoplasms, Male; Salivary Gland Neoplasms; Neoplasms; Carcinoma, Adenoid Cystic; Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms; Carcinoma, Mucoepidermoid; Carcinoma, Acinar Cell; Urogenital Neoplasms; Prostatic Diseases | Details |
| Prostate cancer subunit vaccine (Progenics) | Phase 1 Clinical | Progenics Pharmaceuticals Inc | Prostatic Neoplasms | Details |
This web search service is supported by Google Inc.
A-Z
